The use of lipolytic drugs.
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001095:Arachidonic Acids / Q000627:therapeutic use; D002087:Butyrates / Q000627:therapeutic use; D002794:Choline / Q000627:therapeutic use; D003918:Dextrothyroxine / Q000627:therapeutic use; D005227:Fatty Acids / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000235:genetics*; D008041:Linoleic Acids / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D010713:Phosphatidylcholines / Q000627:therapeutic use; D013261:Sterols / Q000627:therapeutic use; D014308:Triparanol / Q000627:therapeutic use; D015049:Zoxazolamine / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D001095:Arachidonic Acids; D002087:Butyrates; D005227:Fatty Acids; D008041:Linoleic Acids; D009539:Nicotinic Acids; D010713:Phosphatidylcholines; D013261:Sterols; D003918:Dextrothyroxine; D014308:Triparanol; D006493:Heparin; D015049:Zoxazolamine; D002794:Choline